Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development.Antimicrobial-resistant infections contribute to millions of deaths worldwide every year.  The Rocket-miR application predicts targets of human miRNAs in bacterial and fungal pathogens, rapidly identifying candidate miRNA-based antimicrobials.  The Rocket-miR application currently supports 24 recognized human pathogens that are relevant to numerous diseases including cystic fibrosis, chronic obstructive pulmonary disease (COPD), urinary tract infections, and pneumonia. 
Rocket-miR
Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development.Antimicrobial-resistant infections contribute to millions of deaths worldwide every year.  The Rocket-miR application predicts targets of human miRNAs in bacterial and fungal pathogens, rapidly identifying candidate miRNA-based antimicrobials.  The Rocket-miR application currently supports 24 recognized human pathogens that are relevant to numerous diseases including cystic fibrosis, chronic obstructive pulmonary disease (COPD), urinary tract infections, and pneumonia. 
Rocket-miR
Rocket-miR, a translational launchpad for miRNA-based antimicrobial drug development.Antimicrobial-resistant infections contribute to millions of deaths worldwide every year.  The Rocket-miR application predicts targets of human miRNAs in bacterial and fungal pathogens, rapidly identifying candidate miRNA-based antimicrobials.  The Rocket-miR application currently supports 24 recognized human pathogens that are relevant to numerous diseases including cystic fibrosis, chronic obstructive pulmonary disease (COPD), urinary tract infections, and pneumonia. 
Rocket-miR